Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10

Journal of Proteome Research
Eric C C YangK W Michael Siu

Abstract

Endometrial carcinoma is a common malignancy in women, being exceeded in incidence only by that of breast, lung, and colorectal cancers. At present, no serum tumor markers are available for the monitoring of endometrial carcinoma patients, and patients with recurrent disease are detected only following the development of symptoms or abnormalities in imaging assessments. Similarly, no screening tools are available for endometrial carcinoma. Protein profiling by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) has proven to be a sensitive and fast method of analysis for small proteins or peptides to yield specific biomarkers. In this study, a variety of normal and malignant endometrial tissue samples were fractionated and analyzed by SELDI-TOF MS (SELDI is a version of MALDI utilizing protein "chips"). A number of proteins displayed differential expression in malignant endometrial tissues. One of the prominent proteins fractionated by weak cation exchange chromatography and displaying enhanced expression in these malignant tissues was identified as chaperonin 10. The increased expression of chaperonin 10 in malignant endometrial tissues was further confirmed by parallel Western blot and ...Continue Reading

References

Apr 12, 1979·Nature·F P NoonanG J Clunie
Mar 1, 1996·Human Reproduction·S TabibzadehA Babaknia
Jun 3, 2000·American Journal of Reproductive Immunology : AJRI·S Athanasas-PlatsisH Morton
Jun 22, 2000·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·A WalchM Werner
Jul 14, 2001·Critical Reviews in Clinical Laboratory Sciences·M J Duffy
Nov 28, 2001·Proteomics·J D WulfkuhleE F Petricoin
Nov 28, 2001·Proteomics·V KnezevicD B Krizman
Dec 12, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M Inoue
Dec 18, 2001·Journal of Mass Spectrometry : JMS·J Peng, S P Gygi
Jan 16, 2002·American Journal of Clinical Pathology·Yuko SugiyamaKatsuhiko Hasumi
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
Apr 3, 2003·Nature Reviews. Cancer·Julia D WulfkuhleEmanuel F Petricoin
Aug 27, 2003·Journal of Proteome Research·John MarshallGeorge Jackowski
Oct 31, 2003·Nature·Lance A LiottaEmanuel Petricoin

❮ Previous
Next ❯

Citations

Nov 7, 2006·Analytical and Bioanalytical Chemistry·Chensong PanHanfa Zou
Sep 6, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Sergio CiordiaJuan-Pablo Albar
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y-W LinT-Y Chu
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·L-R ZhuQ-P Liao
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y-W LinT-Y Chu
Jun 6, 2009·Reproductive Sciences·Jessica G ScotchieSteven L Young
Oct 29, 2005·BMC Cancer·Francesco CappelloGiovanni Zummo
Apr 15, 2011·Journal of Hematology & Oncology·Yi-sheng WangCong-jian Xu
Apr 3, 2008·Journal of Zhejiang University. Science. B·Li-rong ZhuQin-ping Liao
Sep 17, 2009·Journal of Cancer Research and Clinical Oncology·Masashi TakanoMieko Shiwa
Oct 1, 2005·Cancer Investigation·John Roboz
May 9, 2013·Archives of Physiology and Biochemistry·Gereon PoschmannKai Stühler
Feb 3, 2007·Taiwanese Journal of Obstetrics & Gynecology·Shao-Pai WuHang-Seng Liu
Dec 23, 2006·Current Opinion in Chemical Biology·Michelle L Reyzer, Richard M Caprioli
Dec 15, 2006·Journal of Chromatography. a·Jose L Luque-Garcia, Thomas A Neubert
Sep 1, 2011·Mass Spectrometry Reviews·Peihong ZhuJohn G Marshall
Jul 26, 2005·Cancer Letters·Tatsuo YoshizakiYuji Murata
Apr 8, 2006·Trends in Pharmacological Sciences·Judith Y M N EngwegenJos H Beijnen
Jul 19, 2005·Medical Hypotheses·Christopher A Maxwell, Linda M Pilarski
May 15, 2012·Reproductive Sciences·Ercan Bastu, John Yeh
Jan 15, 2011·Current Opinion in Obstetrics & Gynecology·Toon Van GorpIgnace Vergote
Apr 16, 2005·Clinical Science·Walter KolchAndrew R Pitt
Jan 1, 2008·Biomarker Insights·Mamoun Ahram, Emanuel F Petricoin
Oct 19, 2019·Cancers·Kelechi NjokuEmma J Crosbie
Jul 21, 2009·Journal of Proteome Research·K W Michael SiuGeorge M Yousef
Jun 11, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Paulina BanachEwa Nowak-Markwitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.